Skip to content

Vasoactive intestinal peptide (VIP, aviptadil) studies: 420 papers with results

Page 5 of 9

  1. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.

    Suzuki A · Cellular signalling · 1994

    In vitro (cells) · 6 results

  2. The effects of neurotensin, vasoactive intestinal polypeptide and other neuropeptides on the secretion of somatostatin from cerebral cortical cells.

    Robbins RJ · Brain research · 1985

    In vitro (cells) · 1 result

  3. Effect of pituitary adenylate cyclase activating polypeptide on vasopressin-induced proliferation of aortic smooth muscle cells: comparison with vasoactive intestinal polypeptide.

    Oiso Y · Biochemistry and cell biology = Biochimie et biologie cellulaire · 1993

    In vitro (cells) · rat · 5 results

  4. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: role of Ca signalling.

    Al Kahtane A · Journal of neuroendocrinology · 2005

    In vitro (cells) · turkey · 5 results

  5. Effects of growth hormone-releasing factor and vasoactive intestinal peptide on proliferation and steroidogenesis of bovine granulosa cells.

    Spicer LJ · Molecular and cellular endocrinology · 1992

    In vitro (cells) · bovine · 2 results

  6. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.

    Goursaud S · Journal of neuroimmunology · 2005

    In vitro (cells) · 4 results

  7. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.

    Chik CL · Journal of neurochemistry · 1996

    In vitro (cells) · 3 results

  8. Homologous and heterologous regulation of the helodermin/vasoactive-intestinal-peptide response in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.

    Abello J · European journal of biochemistry · 1989

    In vitro (cells) · mouse · 4 results

  9. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.

    Nagakawa O · Oncology reports · 2005

    In vitro (cells) · 3 results

  10. Processing of vasoactive intestinal peptide and transferrin in human cancerous colonic cells.

    Phan HH · Peptides · 1992

    In vitro (cells) · 4 results

  11. A new vasoactive intestinal peptide antagonist discriminates VIP receptors on guinea pig trachea and human neuroblastoma cells.

    Leroux F · Regulatory peptides · 1994

    In vitro (cells) · 3 results

  12. Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2.

    Prost A · Bioscience reports · 1984

    In vitro (cells) · 3 results

  13. Vasoactive intestinal polypeptide stimulates cyclic AMP production in mouse N1E-115 neuroblastoma cells: modulation by a protein kinase C activator and ionomycin.

    Inukai T · Peptides · 1994

    In vitro (cells) · mouse · 3 results

  14. Comparison of vasoactive intestinal peptide-mediated protein phosphorylation in human lymphoblasts and colonic epithelial cells.

    O'Dorisio MS · Molecular immunology · 1989

    In vitro (cells) · 5 results

  15. Vasoactive intestinal peptide, a singlet oxygen quencher.

    Misra BR · The Journal of biological chemistry · 1990

    In vitro (cell-free) · 4 results

  16. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.

    Dickinson KE · Peptides · 1986

    In vitro (cell-free) · rat and guinea pig · 8 results

  17. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.

    Rorstad OP · Molecular pharmacology · 1990

    In vitro (cell-free) · bovine and rat · 1 result

  18. Characterization of peptidylglycine alpha-amidating activities in rat pituitary, brain and small intestine using glycine-extended C-terminal analogues of vasoactive intestinal polypeptide as substrate.

    Noguchi M · The Tohoku journal of experimental medicine · 1988

    In vitro (cell-free) · rat · 3 results

  19. Neural release of vasoactive intestinal peptide from the gut.

    Bitar KN · Gastroenterology · 1980

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 16 results

  20. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.

    Yaksh TL · Brain research · 1982

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 11 results

  21. Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.

    Hyde JF · Journal of neuroendocrinology · 1996

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 10 results

  22. Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

    Hsu DW · The American journal of pathology · 1989

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 9 results

  23. Alterations in hypothalamic vasoactive intestinal peptide-like immunoreactivity are associated with reproduction and prolactin release in the female turkey.

    Mauro LJ · Endocrinology · 1989

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 8 results

  24. Vasoactive intestinal polypeptide and substance P in primary afferent pathways to the sacral spinal cord of the cat.

    Kawatani M · The Journal of comparative neurology · 1985

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 8 results

  25. Vasoactive intestinal polypeptide cerebrospinal fluid-contacting neurons of the monkey and cat spinal central canal.

    LaMotte CC · The Journal of comparative neurology · 1987

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 8 results

  26. Vasoactive intestinal polypeptide (VIP) innervation of rat spleen, thymus, and lymph nodes.

    Bellinger DL · Peptides · 1997

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 8 results

  27. Immunohistochemical localization of vasoactive intestinal polypeptide (VIP)-containing neurons in the hypothalamus of the Japanese quail, Coturnix coturnix.

    Yamada S · Cell and tissue research · 1982

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 7 results

  28. Vasoactive intestinal polypeptide-containing cells in the rabbit retina: immunohistochemical localization and quantitative analysis.

    Casini G · The Journal of comparative neurology · 1991

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 7 results

  29. Vasoactive intestinal peptide (VIP) in magnocellular neurons of the hypothalamo-neurohypophysial system of the mink (Mustela vision) is co-localized with vasopressin or oxytocin.

    Larsen PJ · The Journal of comparative neurology · 1992

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 8 results

  30. Distribution of vasoactive intestinal polypeptide-immunoreactive structures in the opossum esophagus.

    Christensen J · Gastroenterology · 1987

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 7 results

  31. Regional brain concentrations of vasoactive intestinal polypeptide in normotensive Wistar-Kyoto and spontaneously hypertensive rats.

    Lewis SJ · Brain research · 1986

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 7 results

  32. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.

    O'Morain C · Gut · 1984

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 6 results

  33. Distribution of vasoactive intestinal polypeptide-, substance P-, enkephalin and neurotensin-like immunoreactive nerves in the chicken gut during development.

    Saffrey MJ · Neuroscience · 1982

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 6 results

  34. Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females.

    Simon RA · Scientific reports · 2021

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 6 results

  35. Changes in adrenal neuropeptides content [peptide 7B2, neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP)] induced by pharmacological and hormonal manipulations.

    Tsuchiya T · Journal of endocrinological investigation · 1990

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 6 results

  36. Differential response of neuropeptide Y, substance P and vasoactive intestinal polypeptide in the rat anterior pituitary gland to alterations in thyroid hormone status.

    Jones PM · The Journal of endocrinology · 1994

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 6 results

  37. VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals.

    Edvinsson L · Cell and tissue research · 1980

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  38. Survey of distribution of substance P, vasoactive intestinal polypeptide, cholecystokinin, neurotensin, Met-enkephalin, bombesin and PHI in the spinal cord of cat, dog, sloth and monkey.

    Yaksh TL · Peptides · 1988

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  39. The regulation of neuropeptide expression in rat anterior pituitary following chronic manipulation of estrogen status: a comparison between substance P, neuropeptide Y, neurotensin, and vasoactive intestinal peptide.

    O'Halloran DJ · Endocrinology · 1990

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  40. Immunocytochemical analysis of calcitonin gene-related peptide and vasoactive intestinal polypeptide in Merkel cells and cutaneous free nerve endings of cats.

    Alvarez FJ · Cell and tissue research · 1988

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  41. Release of vasoactive intestinal peptide from rat brain slices by various depolarizing agents.

    Besson J · Neuroscience letters · 1982

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  42. Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats.

    Prysor-Jones RA · The Journal of endocrinology · 1988

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  43. Influence of the L-arginine-nitric oxide pathway on vasoactive intestinal polypeptide release and motility in the rat stomach in vitro.

    Willis S · European journal of pharmacology · 1996

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  44. Vasoactive intestinal peptide (VIP): a new neuroendocrine marker of clinical progression in chronic heart failure?

    Lucia P · Clinical endocrinology · 2003

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  45. Effect of acupuncture on vasoactive intestinal peptide in ischemic cerebrovascular diseases.

    Zhang X · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 1997

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  46. Blood levels of vasoactive intestinal polypeptide in normal and growth retarded fetuses: relationship with acid-base and haemodynamic status.

    Rizzo G · Early human development · 1995

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  47. Angiotensin II regulates the metabolism but not the secretion of vasoactive intestinal peptide in the rabbit.

    Davis RE · Clinical science (London, England : 1979) · 1992

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 5 results

  48. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.

    Köves K · Neuroendocrinology · 1991

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 4 results

  49. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.

    Bishop AE · Gastroenterology · 1980

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 4 results

  50. Origin and distribution of neuropeptide Y-, vasoactive intestinal polypeptide-and substance P-containing nerve fibers in the urinary bladder of the rat.

    Mattiasson A · Cell and tissue research · 1985

    Measured the body's own Vasoactive intestinal peptide (VIP, aviptadil) · 4 results

How PepBank reports evidence